1. Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD. Issue 1 (December 2016) Authors: Beier, Jutta; Pujol, Helena; Seoane, Beatriz; Jimenez, Eulalia; Astbury, Carol; Massana, Eric; Ruiz, Sandrine; de Miquel, Gonzalo Journal: BMC pulmonary medicine Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of abediterol (LAS100977), a novel long‐acting Β2‐agonist. (8th July 2014) Authors: Timmer, Wolfgang; Massana, Eric; Jimenez, Eulalia; Seoane, Beatriz; de Miquel, Gonzalo; Ruiz, Sandrine Journal: Journal of clinical pharmacology Issue: Volume 54:Number 12(2014:Dec.) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD. Issue 4 (7th April 2022) Authors: Singh, Dave; Beier, Jutta; Astbury, Carol; Belvisi, Maria G.; Da Silva, Carla A.; Jauhiainen, Alexandra; Jimenez, Eulalia; Lei, Alejhandra; Necander, Sofia; Smith, Jaclyn A.; Wählby Hamrén, Ulrika; Xin, Wenjing; Psallidas, Ioannis Journal: European respiratory journal Issue: Volume 59:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗